🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The specific clinical trial is a part in which ALK- Abelló will directly wo...
Status
Completed
Location
Hospital Universitario de La Princesa
Start Date
2009-09
Trial ID
NCT02437786
Treatments Being Tested
The purpose of this study is to investigate if immunotherapy with Grazax is...
Status
Completed
Location
Tangstedter Landstrasse 77
Start Date
2006-11
Trial ID
NCT00408616
Treatments Being Tested
The purpose of this study is to assess the safety profile of specific immun...
Status
Completed
Location
Centre Hospitalier Universitaire
Start Date
2007-11
Trial ID
NCT01433510
Treatments Being Tested
Hay fever affects 1 in 4 of the UK population and has significant effects o...
Status
Completed
Location
Royal Brompton Hospital
Start Date
2019-09-26
Trial ID
NCT04078009
Adherence to treatment is crucial to the efficacy of sublingual immunothera...
Status
Completed
Location
Fondazione IRCCS Policlinico San Matteo
Start Date
2007-03
Trial ID
NCT01728285
Treatments Being Tested
This trial is performed to assess whether the Grazax® treatment compliance ...
Status
Completed
Location
Allgergie - Ambulatorium Rennweg
Start Date
2006-02
Trial ID
NCT00293046
Treatments Being Tested
This trial is an exploratory randomised, parallel-group, double-blind, plac...
Status
Completed
Location
Hospital Universitario de La Princesa
Start Date
2013-04
Trial ID
NCT01854736
The primary objective of this study is to assess whether the combination of...
Status
Completed
Location
Royal Brompton Hospital
Start Date
2020-11-05
Trial ID
NCT04502966
Treatments Being Tested
This trial is performed to assess whether the Grazax-R treatment is safe to...
Status
Completed
Location
Tangstedter Landstrasse 77
Start Date
2006-02
Trial ID
NCT00298701
Treatments Being Tested
To investigate the immunologic effects and safety of 60-day treatment of th...
Status
Completed
Location
Research facility ID ORG-001086
Start Date
2014-10
Trial ID
NCT02245360
Treatments Being Tested